https://www.nytimes.com/2021/01/18/briefing/ By David

New Post Public Reply Private Reply Replies (1) Message Board
TedJ
464
https://www.nytimes.com/2021/01/18/briefing/

By David Leonhardt
Jan. 18, 2021, 6:27 a.m. ET

Good morning. We explain why the vaccine news is better than you may think.

‘We’re underselling the vaccine’

Early in the pandemic, many health experts — in the U.S. and around the world — decided that the public could not be trusted to hear the truth about masks. Instead, the experts spread a misleading message, discouraging the use of masks.

Their motivation was mostly good. It sprung from a concern that people would rush to buy high-grade medical masks, leaving too few for doctors and nurses. The experts were also unsure how much ordinary masks would help.

But the message was still a mistake.

It confused people. (If masks weren’t effective, why did doctors and nurses need them?) It delayed the widespread use of masks (even though there was good reason to believe they could help). And it damaged the credibility of public health experts.

“When people feel as though they may not be getting the full truth from the authorities, snake-oil sellers and price gougers have an easier time,” the sociologist Zeynep Tufekci wrote early last year.

Now a version of the mask story is repeating itself — this time involving the vaccines. Once again, the experts don’t seem to trust the public to hear the full truth.

This issue is important and complex enough that I’m going to make today’s newsletter a bit longer than usual. If you still have questions, don’t hesitate to email me at themorning@nytimes.com.

‘Ridiculously encouraging’

Right now, public discussion of the vaccines is full of warnings about their limitations: They’re not 100 percent effective. Even vaccinated people may be able to spread the virus. And people shouldn’t change their behavior once they get their shots.

These warnings have a basis in truth, just as it’s true that masks are imperfect. But the sum total of the warnings is misleading, as I heard from multiple doctors and epidemiologists last week.

“It’s driving me a little bit crazy,” Dr. Ashish Jha, dean of the Brown School of Public Health, told me.

“We’re underselling the vaccine,” Dr. Aaron Richterman, an infectious-disease specialist at the University of Pennsylvania, said.

“It’s going to save your life — that’s where the emphasis has to be right now,” Dr. Peter Hotez of the Baylor College of Medicine said.

The Moderna and Pfizer vaccines are “essentially 100 percent effective against serious disease,” Dr. Paul Offit, the director of the Vaccine Education Center at Children’s Hospital of Philadelphia, said. “It’s ridiculously encouraging.”

The details
Here’s my best attempt at summarizing what we know:

The Moderna and Pfizer vaccines — the only two approved in the U.S. — are among the best vaccines ever created, with effectiveness rates of about 95 percent after two doses. That’s on par with the vaccines for chickenpox and measles. And a vaccine doesn’t even need to be so effective to reduce cases sharply and crush a pandemic.

If anything, the 95 percent number understates the effectiveness, because it counts anyone who came down with a mild case of Covid-19 as a failure. But turning Covid into a typical flu — as the vaccines evidently did for most of the remaining 5 percent — is actually a success. Of the 32,000 people who received the Moderna or Pfizer vaccine in a research trial, do you want to guess how many contracted a severe Covid case? One.

Although no rigorous study has yet analyzed whether vaccinated people can spread the virus, it would be surprising if they did. “If there is an example of a vaccine in widespread clinical use that has this selective effect — prevents disease but not infection — I can’t think of one!” Dr. Paul Sax of Harvard has written in The New England Journal of Medicine. (And, no, exclamation points are not common in medical journals.) On Twitter, Dr. Monica Gandhi of the University of California, San Francisco, argued: “Please be assured that YOU ARE SAFE after vaccine from what matters — disease and spreading.”

The risks for vaccinated people are still not zero, because almost nothing in the real world is zero risk. A tiny percentage of people may have allergic reactions. And I’ll be eager to see what the studies on post-vaccination spread eventually show. But the evidence so far suggests that the vaccines are akin to a cure.

Offit told me we should be greeting them with the same enthusiasm that greeted the polio vaccine: “It should be this rallying cry.”

The costs of negativity
Why are many experts conveying a more negative message?

Again, their motivations are mostly good. As academic researchers, they are instinctively cautious, prone to emphasizing any uncertainty. Many may also be nervous that vaccinated people will stop wearing masks and social distancing, which in turn could cause unvaccinated people to stop as well. If that happens, deaths would soar even higher.

But the best way to persuade people to behave safely usually involves telling them the truth. “Not being completely open because you want to achieve some sort of behavioral public health goal — people will see through that eventually,” Richterman said. The current approach also feeds anti-vaccine skepticism and conspiracy theories.

After asking Richterman and others what a better public message might sound like, I was left thinking about something like this:

We should immediately be more aggressive about mask-wearing and social distancing because of the new virus variants. We should vaccinate people as rapidly as possible — which will require approving other Covid vaccines when the data justifies it.

People who have received both of their vaccine shots, and have waited until they take effect, will be able to do things that unvaccinated people cannot — like having meals together and hugging their grandchildren. But until the pandemic is defeated, all Americans should wear masks in public, help unvaccinated people stay safe and contribute to a shared national project of saving every possible life.

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stephanie Knepp Joins Exceptional Women Alliance

Updated Category News Views 105

A New Chapter for a Seasoned Leader When a high flyer like Stephanie Knepp steps into a new arena, you know folks are going to sit up and pay attention. This time, she's making waves by joining the Exceptional Women Alliance (EWA), a heavy-hitting community of women leaders. With her extensive background in scaling businesses and empowering leaders, she's bound to bring...

Continue Reading
Qfin Holdings Faces Securities Fraud Class Action Challenges

Updated Category News Views 73

Troubles Mount for Qfin Holdings Well, you don't need a crystal ball to see this storm brewing for Qfin Holdings, Inc. (NASDAQ:QFIN). On the heels of a nasty 18.91% nosedive in their stock price, a class action lawsuit is looming overhead like a mischievous cloud ready to rain on investors' parades. It's the kind of legal and financial brew that could leave shareholders...

Continue Reading
Direct Connection Unleashes Powerful HEMI V8 Engine Programs

Updated Category News Views 75

HEMI V8 Legacy Reinvention at SEMA 2026 If you're the sort who gets their hands greasy restoring or revamping classic muscle, well, Direct Connection just made your life a whole lot easier. Stellantis' performance arm pulled the wraps off not just one, but six new HEMI V8 crate engine packages at the 2026 SEMA Show. Now, that's how you turn heads in Vegas. A New...

Continue Reading
Lumentum Holders Question Marvell Deal Fairness: Legal Eyes

Updated Category News Views 73

What's Brewing with Lumentum and Marvell? There's no denying the chatter on Wall Street when there's a potential shake-up, especially with a big merger at stake. We're staring down the barrel of an investigation concerning Lumentum Holdings Inc. (NASDAQ: LITE) and Marvell Technology, Inc.'s deal. The M&A Class Action Firm, helmed by Juan Monteverde, is the name leading...

Continue Reading
PrimeBOT: Breaking Tech Molds with Celeb Backing

Updated Category News Views 62

Not Your Average Tech Buzz It starts with Hollywood glitz and an unexpected dance partner. The PrimeBOT, a Chinese personal robot, is ditching the drab tech corner and seeping into mainstream culture. Imagine Johnny Depp slapping some paint on this machine alongside local kids. Now, picture the Kardashians casually dining with it, letting it join their lunchtime...

Continue Reading
Synova Global Taps Eventus for Top Trade Surveillance

Updated Category News Views 151

Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...

Continue Reading
Moberg Pharma Secures U.S. Patent for MOB-015 Innovation

Updated Category News Views 171

Moberg Pharma's Fresh U.S. Patent: A Game Changer? Moberg Pharma just snagged a U.S. patent for their whiz-bang dosing of MOB-015. Yup, the FDA’s go-ahead is still out of reach, but this patent is like hitting a full house on the river—sweetening the pot significantly. It's all about onychomycosis, or nail fungus, if you're not up on your medical terms. With patent...

Continue Reading
NJ Small Businesses: Free IT Security Checks Offered

Updated Category News Views 86

Unpacking Corporate Technologies' Offer It's not every day a company doles out free consultations, but Corporate Technologies is doing just that. They're tossing New Jersey's small-to-mid businesses a lifeline with free IT and cybersecurity assessments. There's no catch, just thirty minutes of pure, no-nonsense evaluation of your tech setup. Couldn’t hurt to know where...

Continue Reading
Wincomm & Portwell Unveil Medical AI Tech at MEDICA 2026

Updated Category News Views 148

MEDICA 2026: Wincomm and Portwell Join Forces November's got one heck of an event lined up with MEDICA 2026, where Wincomm and Portwell are teaming up to showcase what they've got up their sleeves in medical AI computing. This whole shebang runs from November 16 to 19, with their setup in Hall 12, Stand C76, Düsseldorf, Germany. But why should investors care? Because...

Continue Reading
Differentia Bio's AI: Transforming Drug Development Dynamics

Updated Category News Views 51

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Continue Reading

Top 5 Most Recently Viewed Articles

Building Transparency and KieranTimberlake Team Up for Tally 2.0

Updated Category News Views 99

Building Transparency Collaborates with KieranTimberlake In a significant stride towards enhancing sustainability in the building sector, Building Transparency has announced its collaboration with KieranTimberlake to develop Tally 2.0, an innovative advancement of the tallyLCA tool. This partnership aims to provide insights into the environmental impact of building...

Continue Reading
Celebrate Big Savings with Stellar's Thanksgiving Mega Bundle!

Updated Category News Views 126

Stellar's Exclusive Thanksgiving Mega Bundle Announcement The renowned leader in data recovery solutions, Stellar, has introduced an exciting Thanksgiving Mega Bundle that captures the attention of both professionals and everyday users. For a limited time, you can acquire eight premium software utilities for just $39.45, representing a staggering 90% discount from the...

Continue Reading
FuelPositive Outlines Key Milestones for Green Ammonia Project

Updated Category News Views 91

FuelPositive's Commitment to Sustainable Agriculture FuelPositive Corporation is making notable progress in sustainable agriculture thanks to its innovative Green Ammonia production technology. The Company’s goal is to empower farmers while reducing their dependence on conventional fertilizers, seamlessly blending innovation with ecological responsibility. Their latest...

Continue Reading
Leadership Transition at Alfred I. duPont Charitable Trust

Updated Category News Views 525

Alfred I. duPont Charitable Trust Welcomes New Leadership In a significant shift within its leadership, the Alfred I. duPont Charitable Trust has announced the appointment of Thomas G. Kuntz as the new chairman. This transition comes as Hugh Durden, the long-standing chairman, retires from active service to take on an Emeritus role after nearly three decades of dedicated...

Continue Reading
Upcoming Announcement for QuoteMedia’s Third Quarter Earnings

Updated Category News Views 164

QuoteMedia Set to Release Q3 Financial Results QuoteMedia, Inc. (OTCQB: QMCI), a prominent name in the market data and financial applications sector, is gearing up to unveil its financial performance for the third quarter of 2025. Investors and stakeholders can mark their calendars for November 14, when detailed results will be disclosed. Details of the Upcoming...

Continue Reading